Status:

RECRUITING

Coronary Flow and Myocardial Viability: the FloVITA Study

Lead Sponsor:

Centre Hospitalier Universitaire de Besancon

Conditions:

Myocardial Infarction

Myocardial Ischemia

Eligibility:

All Genders

18-80 years

Brief Summary

Evaluation of fractional flow reserve (FFR) is a key method for assessing ischemia with a view to guiding revascularization strategy following acute coronary syndrome. A stenosis that appears to be se...

Eligibility Criteria

Inclusion

  • Inclusion criteria for the STEMI group:
  • ST segment elevation MI ≥7 days treated by angioplasty of the left anterior descending (LAD) artery
  • Scheduled to undergo angiography for fractional flow reserve (FFR) assessment of a lesion other than the infarct-related artery.
  • Inclusion criteria for the control group:
  • patients undergoing non-urgent coronary angiography for stable angina or silent ischemia
  • with measure of the FFR on one or more vessels (intermediate lesion \<90% without proven ischemia)
  • absence of any significant lesion on the LAD (as assessed by angiography or FFR\>0.8)
  • Inclusion criteria for both groups:
  • Written informed consent
  • Affiliation to a social security regimen (or beneficiary thereof).

Exclusion

  • Target vessel (LAD) not permeable.
  • FFR \<0.8 in the LAD
  • Coronary spasm
  • Left ventricular ejection fraction \<0.50 or a history of anterior MI in patients in the control group
  • Hypertrophic cardiomyopathy
  • Severe valvular heart disease
  • History of coronary artery bypass graft
  • Patients with limited legal capacity or patients under guardianship/tutorship
  • Patients with anticipated poor compliance as assessed by the investigator
  • Patients not affiliated to any social security regime.
  • Pregnant women.
  • Subjects within the exclusion period of another clinical trial as noted in the national registry of research volunteers

Key Trial Info

Start Date :

May 19 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 20 2024

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT04818918

Start Date

May 19 2021

End Date

August 20 2024

Last Update

February 1 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU Besancon

Besançon, France, 25000